Patna, October 12, 2020: Bayer Crop Science, a leading player in Indian agriculture has launched ‘DKC 9188’, a high-yielding hybrid corn seed for progressive corn farmers in Bihar. With DKC 9188, farmers can look forward to higher yields of superior quality corn in the upcoming Rabi season. 

Corn is India’s third-largest cereal crop (after rice and wheat), with cultivation across 9 million hectares. Besides being a staple food crop, corn is used as animal feed & biofuel and finds use in a wide range of industrial food products. This makes corn an emerging cereal crop of significant importance for India’s national food security. Currently, corn production in India stands at 27 million tons, with an average productivity of 3 tons per hectare, compared to global averages of ~5.8 tons per hectare. USA is the world’s leading corn producer with a production average of 11 metric tons per hectare.

Bihar with its fertile soils and hardworking farmers is India’s leading corn-producing state, accounting for approximately more than two-thirds of Rabi corn production. Corn farmers in Bihar harvest more than 10 metric tons per hectare, far exceeding India’s average corn productivity and quite close to USA’s production levels. To increase India’s overall corn productivity and ensure sustainable farm incomes, farmers need high-yielding hybrid seeds and efficient crop management to prevent losses caused by diseases and insects. 

DKC 9188 is Bayer’s latest product offering from its DEKALB® brand portfolio of high-yielding hybrid corn seeds that enjoys immense trust from Indian farmers. Speaking about the new corn hybrid, Simon Wiebusch, Chief Operating Officer, Bayer Crop Science, said, “DKC 9188 with its high yield potential, wider adaptability and strong plant type will empower Bihar’s progressive farmers to boost their corn yields and improve Bihar’s contribution to India’s national corn output. Farmers in the state are already leading the way in terms of corn production and adoption of new technologies. Bayer is committed to support corn farmers with innovative seed and crop protection products along with integrated crop solutions to help them achieve higher productivity and profitability per acre.”

Bayer markets 25 DEKALB® hybrids in India, all of which have been bred and developed specifically to suit India’s diverse agronomic and climatic conditions. DKC 9188 in particular provides better plant strength compared to other hybrids and delivers uniform, long corn cobs and shiny grains with strong yield stability and higher yield potential. This new corn hybrid is suited to multiple soil types and a wider sowing window and provides farmers flexibility in their planting decisions. It is best suited for planting from October 15 onwards and will help corn farmers achieve high returns even in difficult weather conditions.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of € 43.5 billion. Capital expenditures amounted to € 2.9 billion and R&D expenses to € 5.3 billion. For more information, go to www.bayer.com.

Media Contact

Saswati Panigrahi
Communications, Bayer CropScience Limited
E-mail: saswati.panigrahi@bayer.com

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.